Stryker has entered a definitive agreement to acquire complete issued and outstanding shares of Inari Medical’s common stock for $80 per share in cash, which equates to a total equity value of nearly ...

On Tuesday, Inari Medical Inc (NARI) stock saw a decline, ending the day at $79.5 which represents a decrease of $-0.05 or -0.06% from the prior close of $79.55. The stock opened at $79.54 and touched ...

Inari Medical (NARI) stock skyrocketed Monday afternoon and again ... life-saving solutions to patients who suffer from peripheral vascular diseases,” Stryker CEO Kevin Lobo said. “These innovations ...

Inari Medical’s product portfolio includes medical ... of “innovative new solutions” and expand its footprint, Inari CEO Drew Hykes said in a news release. For the first nine months of ...

Charles R. Goulding and Preeti Sulibhavi examine how Stryker's acquisition of Inari Medical is set to transform vascular care ...

Oppenheimer has recently initiated Inari Medical Inc (NARI) stock to Outperform rating, as announced on December 17, 2024, according to Finviz. Earlier, on September 18, 2024, Stifel had initiated the ...

Investing.com -- Inari Medical Inc (NASDAQ ... patients who suffer from peripheral vascular diseases,” said Stryker CEO Kevin Lobo. “These innovations elevate the standard of care for venous ...

U.S. stock futures are little changed after indexes were mixed Monday; Nvidia stock adds to all-time high after CEO comments; and Uber shares climb after it announces collaboration with Nvidia on ...

Inari Medical CEO Drew Hykes said: “Inari has positively impacted the lives of hundreds of thousands of patients through the development of purpose-built tools that address unmet patient needs.

Inari Medical Inc., one of Orange County’s fastest-growing medical device makers, is being acquired for $4.9 billion by ...